TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. By Cancer History Project January 14, 2005
TCL Archive Also in This 8-page Issue: NCI Seeks $6.17 Billion in “Bypass” Budget Request, But Faces Shortfall In Its Actual Budget. By Cancer History Project January 14, 2005
TCL Archive NCI Names 15 to Director’s Consumer Liaison Group. By Cancer History Project January 14, 2005
TCL Archive SAIC-Frederick Makes Awards To Proteomics Research Teams. By Cancer History Project January 14, 2005
Article Robert Mayer talks about the half-century of misses that preceded the development of daraxonrasib By Cancer History Project
Primary Source Backwater to Blockbuster: St. Jude Children’s Research Hospital By Cancer History Project
